Bethany Monteith

Dr. Bethany Monteith is an Assistant Professor in the Division of Hematology within the Department of Medicine at Queen’s University. She holds a cross-appointment in the Department of Oncology and is affiliated with the Canadian Cancer Trials Group (myeloma and lymphoma working groups) and the Canadian Myeloma Research Group. Her clinical practice focuses on malignant hematology, particularly plasma cell dyscrasias and multiple myeloma. Her research emphasizes cost-effectiveness analyses, clinical trial access optimization, and cost-minimization strategies in hematology care.

Education:

• BScKin (Clinical Biomechanics) – University of New Brunswick
• Medical Degree – University of Ottawa (2012)
• Internal Medicine and Hematology Residencies – Queen’s University
• Research Fellowship – Canadian Cancer Trials Group (2021)
• Master of Science in Translational Medicine (2021)

Research Interests:

Dr. Monteith’s research spans hematology, hematological oncology, and health economics. Key areas include:

• Clinical trial methodology in multiple myeloma
• Access to care for hematology patients
• Cost-effectiveness of novel therapies
• Biostatistical methods in clinical research

Professional Affiliations:

• Canadian Cancer Trials Group (Myeloma and Lymphoma Working Groups)
• Canadian Myeloma Research Group
• Cross-appointment in Translational Institute of Medicine (TIME), Queen’s University

Grants and Advising:

While specific grants or trainees are not listed, her work involves collaborative research through clinical trials and institutional programs. She contributes to multidisciplinary teams focused on advancing hematologic malignancy treatments.

Labs/Teams:

Active in translational research through the Translational Institute of Medicine (TIME) and the Canadian Cancer Trials Group, focusing on bridging clinical practice and research innovation.